101 related articles for article (PubMed ID: 5677233)
21. An in vitro model for soluble drug absorption.
Perrin J
J Pharm Pharmacol; 1967 Jan; 19(1):25-31. PubMed ID: 4382171
[No Abstract] [Full Text] [Related]
22. Studies on powdered preparations. XIX. Dissolution kinetics of benzoic acid derivatives.
Nogami H; Nagai T; Ito K
Chem Pharm Bull (Tokyo); 1966 Apr; 14(4):351-7. PubMed ID: 5939310
[No Abstract] [Full Text] [Related]
23. Influence of various starches on dissolution rate of salicylic acid from tablets.
Underwood TW; Cadwallader DE
J Pharm Sci; 1972 Feb; 61(2):239-43. PubMed ID: 5059790
[No Abstract] [Full Text] [Related]
24. Non-diffusional dissolution behaviour of benzoic acid [proceedings].
Donbrow M; Touitou E
J Pharm Pharmacol; 1977 Dec; 29 Suppl():3P. PubMed ID: 22659
[No Abstract] [Full Text] [Related]
25. The interaction of benzoic acid and chloroxylenol with cetomacrogol.
Mitchell AG; Brown KF
J Pharm Pharmacol; 1966 Feb; 18(2):115-25. PubMed ID: 4380751
[No Abstract] [Full Text] [Related]
26. Effect of various parameters upon diffusion-controlled dissolution of benzoic acid.
Braun RJ; Parrott EL
J Pharm Sci; 1972 Apr; 61(4):592-7. PubMed ID: 5014318
[No Abstract] [Full Text] [Related]
27. The influence of metals on the electronic system of biologically important ligands. Spectroscopic study of benzoates, salicylates, nicotinates and isoorotates. Review.
Lewandowski W; Kalinowska M; Lewandowska H
J Inorg Biochem; 2005 Jul; 99(7):1407-23. PubMed ID: 15927261
[TBL] [Abstract][Full Text] [Related]
28. Effect of pH and citrate ions on adsorption of benzoic acid by sulfamethazine.
Nasipuri RN; Khalil SA
J Pharm Sci; 1974 Jun; 63(6):956-8. PubMed ID: 4851690
[No Abstract] [Full Text] [Related]
29. Quantitative determination of salicylic acid and benzoic acid in ointments.
Das Gupta V
J Pharm Sci; 1972 Oct; 61(10):1625-6. PubMed ID: 5072411
[No Abstract] [Full Text] [Related]
30. [The effect of the sodium salts of benzoic and salicylic acids, of their para-amino compounds, and of salicylamide on oxygen consumption and body temperature of the rat].
BALOGH L; DONHOFFER S; MESTYAN G; PAP T; TOTH I
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1952; 214(3):299-307. PubMed ID: 14934168
[No Abstract] [Full Text] [Related]
31. [SURFACE TENSION AND THE FORMATION OF MOLECULAR COMPOUNDS. IV. MOLECULAR ASSOCIATIONS OF CAFFEINE].
PRIOLI G; MONTANINI I
Boll Chim Farm; 1964 May; 103():345-50. PubMed ID: 14188251
[No Abstract] [Full Text] [Related]
32. Solubility profiles for antipyrine and aminopyrine in hydroalcoholic solutions.
Paruta AN
J Pharm Sci; 1967 Dec; 56(12):1565-9. PubMed ID: 5588706
[No Abstract] [Full Text] [Related]
33. Hydrolysis of protolytic esters. V. Alkaline hydrolysis of some acetylenic esters.
Agren A
Acta Pharm Suec; 1965 Nov; 2(5):387-91. PubMed ID: 5858056
[No Abstract] [Full Text] [Related]
34. [The effect of sodium--phenyl--dimethyl pyrazolone methyl amino methane sulfonate and procaine on the stability of vitamine B12].
Izgü E
Turk Hij Tecr Biyol Derg (1961); 1967; 27(1):14-38. PubMed ID: 6043583
[No Abstract] [Full Text] [Related]
35. Investigation of some complexes formed in solution by caffeine. III. Interactions between caffeine and aspirin, p-hydroxybenzoic acid, m-hydroxybenzoic acid, salicylic acid, salicylate ion, and butyl paraben.
HIGUCHI T; ZUCK DA
J Am Pharm Assoc Am Pharm Assoc; 1953 Mar; 42(3):138-45. PubMed ID: 13034652
[No Abstract] [Full Text] [Related]
36. [Investigations on the biological and pharmacological properties of the 4-ureidosalicylic acid and 4-ureidobenzoic acid].
FRIMMER M; WEINDEL I
Arzneimittelforschung; 1951 Sep; 1(6):271-3. PubMed ID: 14934542
[No Abstract] [Full Text] [Related]
37. The isolation, identification and properties of 2,3-dihydro-2,3-dihydroxybenzoic acid. An intermediate in the biosynthesis of 2,3-dihydroxybenzoic acid.
Young IG; Jackman LM; Gibson F
Biochim Biophys Acta; 1969 May; 177(3):381-8. PubMed ID: 5787237
[No Abstract] [Full Text] [Related]
38. [Combined use of bucolome and pyrazolone derivatives (II). Complex formation due to interaction between bucolome and pyrazolones].
Nozaki M
Nihon Yakurigaku Zasshi; 1975 Sep; 71(6):631-9. PubMed ID: 282
[TBL] [Abstract][Full Text] [Related]
39. [Results of salicylate and pyrazolone therapy in Condorelli's endemic Sicilian-Calabrian form of encephalitis].
BERTAZZI CG
G Clin Med; 1955 Feb; 36(2):237-42. PubMed ID: 14391628
[No Abstract] [Full Text] [Related]
40. The relative potencies of some substituted salicylic acids as metabolic stimulants in the intact rat.
ANDREWS MM
Br J Pharmacol Chemother; 1958 Dec; 13(4):419-23. PubMed ID: 13618547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
